REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,126,997 | -1.8% | 109,131 | -12.4% | 0.03% | -12.5% |
| Q1 2023 | $11,326,814 | +105.0% | 124,580 | -14.3% | 0.03% | +88.2% |
| Q4 2022 | $5,525,418 | +357.0% | 145,444 | +202.3% | 0.02% | +325.0% |
| Q3 2022 | $1,209,000 | -55.1% | 48,115 | -52.8% | 0.00% | -33.3% |
| Q4 2021 | $2,690,000 | -63.9% | 102,002 | +97.4% | 0.01% | -90.2% |
| Q1 2020 | $7,460,000 | +261.4% | 51,682 | +114.0% | 0.06% | +771.4% |
| Q1 2019 | $2,064,000 | – | 24,147 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |